Two Different Contact Sites Are Recruited by Cardiotrophin-like Cytokine (CLC) to Generate the CLC/CLF and CLC/sCNTFRα Composite Cytokines*

The cytokines of the interleukin-6 family are multifunctional proteins that regulate cell growth, differentiation, and other cell functions in a variety of biological systems including the immune, inflammatory, hematopoietic, and nervous systems. One member of this family, ciliary neurotrophic factor (CNTF), displays biological functions more restricted to the neuromuscular axis. We have recently identified two additional ligands for the CNTF receptor complex. Both are composite cytokines formed by cardiotrophin-like cytokine (CLC) associated to either the soluble type I cytokine receptor CLF or the soluble form of CNTF receptor α (CNTFRα). The present study was aimed at analyzing the interactions between the cytokine CLC and its different receptor chains. For this purpose, we modeled CLC/receptor interactions to define the residues potentially involved in the contact sites. We then performed site-directed mutagenesis on these residues and analyzed the biological interactions between mutants and receptor chains. Importantly, we found that CLC interacts with the soluble forms of CNTFRα and CLF via sites 1 and 3, respectively. For site 1, the most crucial residues involved in the interaction are Trp67, Arg170, and Asp174, which interact with CNTFRα. Surprisingly, the residues that are important for the interaction of CLC with CLF are part of the conserved FXXK motif of site 3 known to be the interaction site of LIFRβ. Obtained results show that the Phe151 and Lys154 residues are effectively involved in the interaction of CLC with LIFRβ. This study establishes the molecular details of the interaction of CLC with CLF, CNTFRα, and LIFRβ and helps to define the precise role of each protein in this functional receptor complex.

[1]  David Perret,et al.  Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Mcclanahan,et al.  WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27 , 2004, The Journal of Immunology.

[3]  David Baker,et al.  Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130. , 2003, Molecular cell.

[4]  S. Chevalier,et al.  Leukemia Inhibitory Factor (LIF), Cardiotrophin-1, and Oncostatin M Share Structural Binding Determinants in the Immunoglobulin-like Domain of LIF Receptor* , 2003, Journal of Biological Chemistry.

[5]  K. Garcia,et al.  Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex , 2003, Science.

[6]  R. Kastelein,et al.  Novel IL-12 family members shed light on the orchestration of Th1 responses , 2003, Trends in Immunology.

[7]  T. Mcclanahan,et al.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. , 2002, Immunity.

[8]  C. Guillet,et al.  Functionally active fusion protein of the novel composite cytokine CLC/soluble CNTF receptor. , 2002, European journal of biochemistry.

[9]  S. Chevalier,et al.  Signaling Pathways Recruited by the Cardiotrophin-like Cytokine/Cytokine-like Factor-1 Composite Cytokine , 2001, The Journal of Biological Chemistry.

[10]  S. Chevalier,et al.  The ciliary neurotrophic factor receptor α component induces the secretion of and is required for functional responses to cardiotrophin‐like cytokine , 2001, The EMBO journal.

[11]  P. Heinrich,et al.  Identification of the domain in the human interleukin-11 receptor that mediates ligand binding. , 2001, Journal of molecular biology.

[12]  Mark A. Hall,et al.  Interleukin-11 Signals through the Formation of a Hexameric Receptor Complex* , 2000, The Journal of Biological Chemistry.

[13]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[14]  D. Higgins,et al.  T-Coffee: A novel method for fast and accurate multiple sequence alignment. , 2000, Journal of molecular biology.

[15]  S. Chevalier,et al.  CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex , 2000, Nature Neuroscience.

[16]  W. Somers,et al.  Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin‐12 , 2000, The EMBO journal.

[17]  J. Heath,et al.  Receptor recognition by gp130 cytokines , 2000, The EMBO journal.

[18]  P. Heinrich,et al.  Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis. , 1999, European journal of biochemistry.

[19]  T. Boone,et al.  Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Ruben,et al.  Computational EST database analysis identifies a novel member of the neuropoietic cytokine family. , 1999, Biochemical and biophysical research communications.

[21]  S. Rose-John,et al.  Receptor Recognition Sites of Cytokines Are Organized as Exchangeable Modules , 1999, The Journal of Biological Chemistry.

[22]  W. Mayo,et al.  Ciliary Neurotrophic Factor is a Regulator of Muscular Strength in Aging , 1999, The Journal of Neuroscience.

[23]  P. Heinrich,et al.  Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. , 1999, Journal of immunology.

[24]  S. Rose-John,et al.  Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. , 1998, Blood.

[25]  P. Heinrich,et al.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.

[26]  G. Ciliberto,et al.  Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. , 1998, The Biochemical journal.

[27]  C Geourjon,et al.  Protein structure prediction. Implications for the biologist. , 1997, Biochimie.

[28]  E. Kieff,et al.  Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Burny,et al.  Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells , 1997, Gene Therapy.

[30]  W. Somers,et al.  1.9 Å crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling , 1997, The EMBO journal.

[31]  S. Chevalier,et al.  Signaling of the Cardiotrophin-1 Receptor , 1997, The Journal of Biological Chemistry.

[32]  G. Ciliberto,et al.  Functional Expression of Soluble Human Interleukin-11 (IL-11) Receptor α and Stoichiometry of in Vitro IL-11 Receptor Complexes with gp130* , 1996, The Journal of Biological Chemistry.

[33]  W. Hendrickson,et al.  Localization of Functional Receptor Epitopes on the Structure of Ciliary Neurotrophic Factor Indicates a Conserved, Function-related Epitope Topography among Helical Cytokines (*) , 1995, The Journal of Biological Chemistry.

[34]  W. Hendrickson,et al.  Crystal structure of dimeric human ciliary neurotrophic factor determined by MAD phasing. , 1995, The EMBO journal.

[35]  K. Chien,et al.  Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Begley,et al.  Cloning of a murine IL‐11 receptor alpha‐chain; requirement for gp130 for high affinity binding and signal transduction. , 1994, The EMBO journal.

[37]  J. Cedarbaum,et al.  Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. , 1994, Science.

[38]  Jianguo Hu,et al.  A null mutation in human CNTF gene is not causally related to neurological diseases , 2022 .

[39]  P. Distefano,et al.  Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle , 1994, Cell.

[40]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[41]  P. Distefano,et al.  Retrograde axonal transport of ciliary neurotrophic factor is increased by peripheral nerve injury , 1993, Nature.

[42]  K. Yasukawa,et al.  IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. , 1993, Science.

[43]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[44]  P. Distefano,et al.  Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses. , 1993, Science.

[45]  H. Thoenen,et al.  Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy , 1992, Nature.

[46]  H. Thoenen,et al.  Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration , 1992, The Journal of cell biology.

[47]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[48]  C. Thut,et al.  Leukemia inhibitory factor receptor is structurally related to the IL‐6 signal transducer, gp130. , 1991, The EMBO journal.

[49]  J. Bazan.  Neuropoietic cytokines in the hematopoietic fold , 1991, Neuron.

[50]  G. Yancopoulos,et al.  The receptor for ciliary neurotrophic factor. , 1991, Science.

[51]  T. Hirano,et al.  Molecular cloning and expression of an IL-6 signal transducer, gp130 , 1990, Cell.

[52]  H. Thoenen,et al.  Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[53]  H. Thoenen,et al.  Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor , 1989, Nature.

[54]  T. Taniguchi,et al.  Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. , 1988, Science.